XML 14 R4.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Revenue:    
Net product sales $ 4,169  
Cost of goods sold 775  
Gross Profit 3,394  
Operating Expenses:    
Research and development 30,876 $ 23,425
Selling, general and administrative 19,132 15,701
Changes in fair value of contingent consideration payable 4,578 3,152
Restructuring charges   50
Depreciation 823 673
Total operating expenses 55,409 43,001
Loss from operations (52,015) (43,001)
Other income (expenses):    
Interest income 759 307
Interest expense (4,290) (945)
Other income (expense) 610 (52)
Loss before income tax benefit (54,936) (43,691)
Income tax expense (56)  
Net loss attributable to common stockholders $ (54,992) $ (43,691)
Net loss attributable to common stockholders per common share - basic and diluted $ (0.39) $ (0.35)
Weighted-average common shares outstanding - basic and diluted 142,770,629 125,178,517